VBI Vaccines
VBIV
#10697
Rank
NZ$3.12 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.33%
Change (1 year)

Earnings for VBI Vaccines (VBIV)

Earnings in 2024 (TTM): -NZ$0.14 Billion

According to VBI Vaccines 's latest financial reports the company's current earnings are NZ$9.41 Million. In 2023 the company made an earning of -NZ$0.16 Billion, an increase over its 2022 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VBI Vaccines from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.14 Billion-11.74%
2023 -NZ$0.16 Billion-18.06%
2022 -NZ$0.19 Billion62.43%
2021 -NZ$0.12 Billion50.88%
2020 -NZ$77.18 Million-15.66%
2019 -NZ$91.51 Million-13.82%
2018 -NZ$0.11 Billion61.32%
2017 -NZ$65.82 Million57.8%
2016 -NZ$41.71 Million-67.39%
2015 -NZ$0.13 Billion1527.36%
2014 -NZ$7.87 Million36.21%
2013 -NZ$5.78 Million-63.91%
2012 -NZ$16 Million-59.19%
2011 -NZ$39.19 Million227.23%
2010 -NZ$11.98 Million1741.53%
2009 -NZ$0.66 Million14.52%
2008 -NZ$0.57 Million-42.93%
2007 -NZ$1 Million21.8%
2006 -NZ$0.82 Million172.39%
2005 -NZ$0.3 Million115.38%
2004 -NZ$0.14 Million-42.27%
2003 -NZ$0.25 Million109.27%
2002 -NZ$0.12 Million17.89%
2001 -NZ$0.1 Million-369.64%
2000 NZ$0.03 M-69.24%
1999 NZ$0.11 M12.77%
1998 NZ$0.1 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$30.31 Million-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-NZ$54.36 Million-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-NZ$0.7 Billion 404.31%๐Ÿ‡บ๐Ÿ‡ธ USA